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Summary The contribution of hereditary factors in basal cell carcinoma of the skin has not been well defined at the population level. We aimed
to assess the hereditary component in basal cell carcinoma by comparing its occurrence in monozygotic and dizygotic twin pairs. The Finnish
Twin Cohort, comprising 12 941 adult, like-sex twin pairs with established zygosity and resident in Finland in 1975, was linked with the Finnish
Cancer Registry. We identified 335 twin pairs in which at least one twin had basal cell carcinoma diagnosed between 1953 and 1996.
Standardized incidence ratios, concordances, tetrachoric correlations and pairwise relative risks were computed by standard methods.
Components of variance in liability were estimated by structural equation modelling. There was an elevated risk of basal cell carcinoma forthe
co-twin of a diseased twin, but no difference in risk by zygosity. During the prospective follow-up in 1976-96, the probandwise concordance
was 7.7% in monozygotic and 7.0% in dizygotic pairs. Model fitting indicated that genetic factors were not needed to accountforthe distribution
of basal cell carcinoma in twin pairs. These results confirm the major role of environmental factors in the aetiology of basal cell carcinoma.
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Both hereditary and environmental factors contribute to the devel-
opment of basal cell carcinoma of the skin (BCC). For example,
solar exposure has been shown to be an important risk factor
(Vitalino and Urbach, 1980; Mackie, 1986; Carter, 1989). The
recessively inherited diseases xeroderma pigmentosum (Kramer et
al, 1977) and epidermodysplasia verruciformis (Lutzner, 1978),
the dominantly inherited Bazex syndrome (Mehta and Potdar,
1985) and the basal cell naevus syndrome (Southwick and
Schwarts, 1979) are examples ofspecific gene disorders known to
be associated with the development of BCC. The influence of
genetic factors is also exemplified by the association of skin
cancer morbidity with fair skin, red hair, an inability to tan and a
propensity to freckle (Vitalino and Urbach, 1980).
At the general population level, the relative role of genetic and
environmental influences on BCC risk has not been quantified.
Family studies can determine the degree of familial aggregation,
but distinguishing genetic factors from environmental exposures
shared by family members can be problematic in studies ofnuclear
families. Twin studies comparing the similarity of monozygotic
(MZ) and dizygotic (DZ) twins for the occurrence of disease
provide an estimate ofthe relative role ofgenetic factors, environ-
mental factors shared by family members and non-shared environ-
mental factors. Large, population-based twin studies are needed to
provide reliable and unbiased estimates. The existence of the
nationwide Finnish Cancer Registry since 1953 and of the adult
Finnish Twin Cohort since 1974 gave us an opportunity to study
patterns offamilial aggregation ofBCC.
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MATERIALS AND METHODS
The Finnish Twin Cohort
The nationwide Central Population Register ofFinland, initiated in
1967, comprises computerized information on all Finnish citizens.
All persons can be identified by a unique ten-digit identification
number. In 1974, the twin cohort ofwhite, adult, like-sex twin pairs
born in Finland was compiled from the central population register
using the selection procedures described elsewhere (Kaprio et al,
1978). In 1975, a baseline questionnaire was posted to all persons
who were aged 18 or older and had an adequate address. An overall
response rate of 89% was obtained. In 93% of the twin pairs, the
questionnaire data enabled the classification of pairs either as MZ
or DZ. This method has been validated in a subsample study (Sarna
et al, 1978). For the purposes of the present study, we included all
12 941 twin pairs ofknown zygosity of whom both co-twins were
alive and living in Finland on 1 January 1976.
Data on basal cell carcinomas of the skin
The BCCs among the study subjects in 1953-96 were identified by
record linkage of the Finnish Twin Cohort data with the Finnish
Cancer Registry data, using the personal identification numbers.
The Finnish Cancer Registry is a nationwide database with infor-
mation on all cases of cancer diagnosed in Finland since 1953
(Finnish Cancer Registry, 1997). The reporting of cancer has been
compulsory since 1961. Notifications on cancer patients are
received independently from several sources such as hospitals,
private physicians and pathological laboratories. All diagnoses of
BCC are based on histological examination because only histolog-
ically verified BCCs are registered. In cases of multiple notifica-
tions ofBCC, only the first within each ofthe ten subsites is taken
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into account (the subsites are: lips, eyelids, ears, other face, scalp
and neck, trunk, upper limbs, lower limbs, multiple parts, unspeci-
fied). IfBCCs occur at different subsites within 1 year, the subsite
'multiple parts' is used. If the interval is more than 1 year, each
BCC is recorded separately.
Assessment of risk in individuals
The study subjects were classified into categories according to
zygosity. Person-years were calculated from 1 January 1976 until
emigration, death or 31 December 1995, whichever occurred first
(year 1996 was excluded from this analysis because reliable inci-
dence rates were not yet available for that year). The observed
numbers of BCC and person-years at risk were counted by sex,
age (5-year age groups) and calendar period (1976-80, 1981-85,
1986-90, 1991-95). The expected numbers of BCCs were calcu-
lated by multiplying the stratum-specific number of person-years
by the corresponding BCC incidence in Finland. The standardized
incidence ratios were calculated by dividing the observed number
ofcases by the number expected. The exact 95% confidence inter-
vals were defined under the assumption that the observed number
ofBCCs followed a Poisson distribution.
Analysis of pairwise occurrence
Twin similarity for dichotomous traits can be summarized using
estimates ofconcordance. Concordance can be assessed using two
concordances (termed pairwise and probandwise), each calculated
separately for MZ and DZ twin pairs (Falconer, 1981; Plomin,
1997). The pairwise concordance is a descriptive statistic and
gives the proportion ofaffected pairs that are concordant for BCC.
The probandwise concordance gives the proportion ofall probands
that belong to concordant pairs. It is informative ofthe recurrence
risk of disease (corresponding to cumulative risk) associated with
the degree of relationship of the pair and this can be compared
with the risk of disease in the population at large, and in different
types ofrelatives.
Another method ofassessing familial aggregation is the relative
risk (RR) of BCC for twins whose co-twin has been diagnosed
with BCC, compared with twins whose co-twin has not been so
diagnosed (Ahlbom et al, 1997). The RR for all twin pairs together
reflects the combined familial effect, whereas a comparison
between MZ and DZ twin pairs may separate a heritable compo-
nent. RRs for all twins and for MZ and DZ twin pairs separately
were estimated by means of the odds ratio obtained from the
numbers ofdisease concordant pairs, disease-free concordant pairs
and discordant pairs.
Genetic modelling
When the number ofunaffected twin pairs in the population or the
population rate of disease is known, more sophisticated models
can be used to estimate the contribution of genetic factors to the
susceptibility to skin cancer. For complex diseases, the polygenic,
multifactorial model is the most frequently used. It assumes that
there is a normally distributed liability to disease. When a certain
level or threshold of liability is reached, the disease becomes
manifest (Falconer, 1981). Both genes and environmental factors
are assumed to contribute to the liability, and the overall liability
results from thejoint effects of many genes with small effects and
a multitude of environmental effects. These assumptions can be
considered reasonable, from what is known about BCC risk
factors.
We used structural equation modelling techniques with the Mx
software package (Neale, 1997) to estimate the variance compo-
nents and to compare different genetic models. Using these tech-
niques, threshold models with additive genetic (A), dominance
(D), shared environmental (C) or unique environmental (E)
sources of variation in the underlying liability to disease can be
fitted to the two by two contingency tables (disease present/absent
in twin one vs. disease present/absent in twin two). Shared envi-
ronmental factors are those common to family members, e.g.
parental socioeconomic status. The contingency tables are set out
for cancer separately for MZ and DZ pairs. The correlation in
disease liability between the two members of each kind of twin
pair is obtained as the tetrachoric correlation; the tetrachoric corre-
lation is the correlation of a bivariate normal distribution that
duplicates the cell probabilities from a two by two contingency
table. The latent variables are assumed to have a bivariate normal
distribution.
In the structural equation models, parameter estimates, their
confidence intervals and goodness-of-fit statistics are computed as
described in detail elsewhere (Heath et al, 1989; Neale, 1997). The
goodness-of-fit statistics assess to what degree the model specified
by the investigators adequately corresponds to the data; a small
goodness-of-fit chi-squared value and high P-value indicates good
correspondence between the model and data. Akaike's information
criterion (AIC) is a statistic that combines information on the
goodness-of-fit and simplicity of the model (Heath et al, 1989).
The best model is, thus, generally the one with the lowest AIC
value. Alternative models that specify different effects can be
compared by assessing the change in chi-squared relative to
changes in the degrees of freedom between models. This permits
assessment of the significance of additive genetic effects, effects
due to dominance, and shared environmental effects to the varia-
tion of disease susceptibility in the population. Heritability is a
population-specific parameter, which gives the proportion of
overall, phenotypic variance attributable to genetic factors
(Falconer, 1981).
RESULTS
There were a total of 372 cases of BCC diagnosed among 351
affected subjects (Table 1) in 1953-96. Of all BCCs, 58 had been
diagnosed in 1953-75, 292 in 1976-95, and 22 in 1996. Ofthe 351
Table 1 Numbers of subjects in the Finnish Twin cohort diagnosed to have
basal cell carcinoma of the skin in 1953-96. Shown by year of diagnosis,
zygosity and sex
Year of diagnosis Male Female Total
1953-96
All 162 189 351
Monozygotic 50 70 120
Dizygotic 162 189 231
1953-75a 32 23 55
1976-96 138 166 304
aThe numbers of affected subjects during 1953-75 and 1976-96 do not add
up to the numbers in 1953-96 because of the occurrence of more than one
case of basal cell carcinoma of the skin in 19 subjects.
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Table 2 Observed (Obs) numbers of basal cell carcinomas of the skin,
standardized incidence ratios (SIRs) and 95% confidence intervals (Cl) in
1976-95. Shown by sex, zygosity and calendar period
Classification Obs SIR 95% Cl
Totala 292 0.93 0.83-1.0
Male 136 0.99 0.83-1.2
Female 156 0.88 0.75-1.0
1976-80 30 0.77 0.52-1.1
1981-85 77 1.20 0.94-1.5
1986-90 72 0.77 0.61-0.97
1991-95 120 1.00 0.83-1.2
Monozygotic
Total 95 0.94 0.76-1.2
Male 39 0.91 0.65-1.3
Female 56 0.97 0.73-1.3
1976-80 12 1.0 0.53-1.8
1981-85 25 1.3 0.84-1.9
1986-90 24 0.88 0.56-1.3
1991-95 32 0.92 0.63-1.3
Dizygotic
Total 197 0.92 0.74-1.1
Male 97 1.0 0.84-1.3
Female 100 0.84 0.68-1.0
1976-80 16 0.69 0.39-1.1
1981-85 41 1.1 0.76-1.4
1986-90 44 0.77 0.56-1.0
1991-95 79 1.1 0.84-1.3
aThe 22 cases of basal cell carcinoma which were diagnosed in 1996 were
excluded from the SIR analyses, because general population data (needed
for the calculation of expected numbers) was incomplete at the time of the
record linkage.
affected subjects, 162 were men; of the 351 affected subjects, 120
were MZ twins (Table 1).
The risk ofBCC in twins was compared with that in the popula-
tion at large during the observation period, 1976-95 (Table 2). The
standardized incidence ratios (SIRs) did not differ from the
expected level either in male (SIR 0.99) or female (0.88) twins, in
MZ (0.91) or DZ (0.92) twins, or during the four calendar periods
(Table 2).
The pairwise distribution of cases of BCC is shown in Table 3.
During the prospective follow-up from 1976 to 1996, there were a
total of 11 concordant pairs and 282 discordant pairs for BCC.
Among MZ twins, there were four concordant and 96 discordant
pairs, which gave a probandwise concordance rate of 7.7% and a
tetrachoric correlation of 0.35. Correspondingly, there were,
among DZ pairs, seven concordant and 186 discordant pairs,
giving a probandwise concordance rate of 7.0% and a tetrachoric
correlation in liability of 0.34. The concordances, tetrachoric
correlations and pairwise relative risk did not differ between men
and women (Table 3). In the analyses combining both retrospec-
tively (1953-75) and prospectively (1976-96) diagnosed cases, a
total of 16 concordant and 319 discordant pairs were observed.
The probandwise concordance was 10% in MZ pairs compared
with 8.7% in DZ pairs, with a pairwise relative risk of8.1 (95% CI
3.3-20) in MZ pairs compared with a relative risk of 7.7 (3.9-15)
in DZ pairs. Data for men and women were very similar (data not
shown). Among the 16 concordant pairs, the median intra-pair
difference in age of diagnosis of the first BCC was 8.5 years for
MZ pairs (range 5-17 years) and 10 years for DZ pairs (range
1-17 years).
Table 3 Numbers of twin pairs concordant and discordant for basal cell carcinoma of the skin, probandwise and pairwise concordance rates, tetrachoric
correlations, relative risks (RR) and 95% confidence intervals (Cl) in 1953-96 shown by calendar period of diagnosis, sex and zygosity
No. No. No. Probandwise Pairwise Tetrachoric RRa 95% Cl




Total 7 124 6222 0.10 0.053 0.44 11 5.0-26
MZ 2 38 1845 0.095 0.050 0.42 10 2.2-47
DZ 5 86 4377 0.10 0.055 0.44 12 4.5-31
Women
Total 4 158 6426 0.048 0.025 0.25 4.1 1.5-12
MZ 2 58 2094 0.065 0.033 0.30 5.0 1.1-22
DZ 2 100 4332 0.038 0.020 0.21 3.5 0.82-15
Men + women
Total 11 282 12648 0.072 0.038 0.34 7.0 3.7-13
MZ 4 96 3939 0.077 0.040 0.35 6.8 2.4-20
DZ 7 186 8709 0.070 0.036 0.34 7.1 3.2-16
1953-96
Men + women
Total 16 319 12606 0.091 0.048 0.38 7.9 4.6-14
MZ 6 108 3925 0.10 0.053 0.39 8.1 3.3-20
DZ 10 211 8681 0.087 0.045 0.37 7.7 3.9-15
aRR comparing those with and those without cancer in co-twin, estimated as ad/bcwhere a = the number of concordant pairs with cancer, b = c = one-half of the
number of discordant pairs and d= the number of concordant pairs without cancer.
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Table 4 Estimates of the components of variance in liability to BCC in 1976-96 based on structural equation model fitting
Proportion of variance (and 95% Cl) explained by variance components
Model Additive genetic Effects due to Shared Individual x2 d.f.a P-value AICb
effects (A) dominance (D) environment (C) environment (E)
ADE 0.46 (0.082-0.61) 0.0 (0.0-0.39) - 0.54 (0.39-0.72) 2.35 3 0.50 -3.65
AE 0.46 (0.28-0.61) - - 0.54 (0.39-0.72) 2.35 4 0.67 -5.65
ACE 0.077 (0.00-0.56) - 0.30 (0.00-0.47) 0.62 (0.43-0.78) 0.086 3 0.99 -5.91
CE _ 0.35 (0.22-0.47) 0.65 (0.53-0.78) 0.16 4 1.00 -7.84
E - - 1.0 24.2 5 <0.001 14.2
ad.f., degrees of freedom; bAIC, Akaike's information criterion.
Several BCCs in only one subject were more common among
twins belonging to the 16 pairs who had been concordantly
affected in 1953-76. Five (two male MZ, two male DZ and one
female DZ twins) out of the 32 subjects had multiple BCCs. The
proportion of twins with multiple BCCs was 16% (5/32) among
the concordantly affected pairs, while it was 4.4% (14/319) among
the affected twins ofthe discordantly affected pairs; the difference
in proportions was not significant at the P = 0.05 level (11%; 95%
CI -1.5-24).
The pattem of tetrachoric correlations from Table 3 (in which
the MZ correlation is seen to be virtually equal to the DZ correla-
tion but both correlations are significantly different from zero)
suggested that shared environmental effects were the most likely
explanation for the pairwise distribution of cases. Nonetheless,
models including genetic effects were also tested (Table 4).
Unshared environmental effects (E model) as the only explana-
tion could be rejected because the E model fitted the data poorly
(P < 0.001) (Table 4). Fitting a model with both shared and
unshared environmental effects (CE model) improved the fit
significantly (chi-squared change = 24, d.f. = 1, P < 0.001)
compared with the E model. This CE model fitted well (P = 1.00)
and had the smallest AIC value ofall models. Further addition ofa
term for additive genetic effects did not improve fit, and the point
estimate for the proportion of phenotypic variance in liability to
BCC due to genetic factors was 7.7% (95% CI 0-56). A model
with only additive genetic and unshared environmental effects
fitted the data less well than a model including shared environ-
mental effects (chi-squared change 2.3, d.f. = 1, P = 0.13). In the
best-fitting CE model, the proportion of phenotypic variance in
liability to BCC accounted for by shared environmental factors
was 35% (95% CI 22-47), and the remainder was accounted forby
environmental factors not shared by the co-twins.
DISCUSSION
Our results show that the risk of BCC in an unselected adult twin
population did not differ from the risk in the population at large.
Secondly, the pattems of pairwise occurrence of BCC were most
consistent with the concept that environmental influences are of
primary importance in the aetiology ofBCC. The role ofhereditary
factors in the pathogenesis ofBCC appears to be moderate at most.
The present data were obtained by linkage of the Finnish Twin
Cohort to the Finnish Cancer Registry records on BCC from 1953
to 1996. The twin cohort was compiled in 1974 without selection
for health status (including BCC or other cancers), and it has been
found to be representative of the general population ofFinland for
general social and demographic characteristics (Kaprio et al,
1979). The age and sex distributions of MZ and DZ twins in the
cohort were very similar. The primary focus of this analysis was
on the prospective follow-up of these twin pairs for new cases of
BCC from 1976 to 1996. Some additional concordance analyses
were conducted using all the BCC cases diagnosed within the
study cohort in 1953-96 to investigate the sensitivity of the risk
estimates for retrospective case selection. Selection owing to
mortality from BCC during the retrospective part of the follow-up
is also unlikely to have affected the results as the 5- and 10-year
relative survival rates of patients with BCC were very close to
100% (Karjalainen et al, 1989).
The analysis ofSIRs over the prospective follow-up period indi-
cated that the incidence of BCC in twins did not differ from the
population incidence either overall or when considered by sex,
zygosity and calendar period. The BCC cases were histologically
confirmed, but the actual coverage ofthe BCC data included in the
Finnish Cancer Registry is not known. However, there is no reason
to suspect that coverage of the routinely collected data on BCCs
would not be the same for twins and singletons, or for MZ and DZ
twins. Similarly, no differences in the morbidity of MZ compared
with DZ twin individuals have been found for common diseases
such as ischaemic heart disease, hypertension and bronchial
asthma, which have a polygenically inherited component
(Jarvinen et al, 1992).
The doubling of incidence rates for BCC in Finland from the
early 1970s up to 1995 (Finnish Cancer Registry, 1997) was
allowed for in the SIR analyses, and the SIRs did not differ by
calendarperiod ofobservation. As the twins in a pair are always of
the same age, they experience the same cohort effects.
Unfortunately, the numbers of affected twins, in particular of
concordant pairs, were too small to permit a detailed analysis by
birth cohort.
The analysis ofpairwise similarity for BCC, using concordance,
tetrachoric correlations and relative risks, showed evidence for
familial aggregation of BCC with no differences by zygosity. The
genetic modelling formally tested altemative models to account for
this result, and provided quantitative estimates of the contribution
of genetic, shared environmental and non-shared environmental
effects on the inter-individual variation in the liability to BCC. A
genetic component was not needed in the models to account for the
pattern ofpairwise similarity. Thus, it appears that the specific gene
disorders known to be associated with the development of BCC
(Kramer et al, 1977; Lutzner, 1978; Southwick and Schwarts, 1979;
Mehta and Potdar, 1985) are not of major importance on the
population level. This does not, however, imply that genetic factors
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would not be relevant to the aetiology and pathogenesis ofBCC, as
indicated by some recently published studies (Hahn et al, 1996;
Dahmane et al, 1997; Oro et al, 1997). However, the small number
ofconcordantly affected twin pairs means that the power to exclude
the presence ofa major genetic effect is not as high as desirable, as
can be observed in the relatively wide confidence intervals for the
variance component estimates.
As for other risk factors, the risk ofBCC has consistently shown
inverse relationships with the degree of skin pigmentation charac-
teristics of the population. Another consistent finding is the posi-
tive association with exposure to solar ultraviolet radiation.
However, the relative importance of solar exposure in the aeti-
ology ofBCC is probably more pronounced in other countries than
in Finland, where the intensity of ultraviolet-B radiation is, for
example, only one-ninth of the intensity encountered across the
equator (Henriksen et al, 1989). Other risk factors of BCC include
old age; male gender; ionizing radiation; chemical carcinogens
such as polycyclic aromatic hydrocarbons, inorganic arsenic and
psoralens; precursor lesions such as solar or actinic keratosis; and
possibly also dietary factors and cigarette smoking (Scotto et al,
1996). These epidemiological risk factors may either be shared or
not shared by family members.
This study suggests that about one-third of the overall variation
in liability to BCC is explained by environmental factors common
to the twins in a pair, with the remainder accounted for by indi-
vidual environmental factors. The shared environmental factors
could include very similar exposures to sun in the childhood, but
also other factors that are shared by family members. The large
proportion oftwin pairs in which only one twin has BCC suggests
that the relevant risk factors for BCC might be identified using a
case-control approach in these discordant pairs.
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